AbCellera to Participate at Upcoming Investor Conferences in September

By: AbCellera Biologics Inc. via Business Wire

August 12, 2025 at 16:05 PM EDT

AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

Wells Fargo Healthcare Conference, September 3-5, 2025
Morgan Stanley Annual Global Healthcare Conference, September 8-10, 2025

Visit AbCellera's Investor Relations website for additional information.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women's health, immunology, and oncology. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250812333835/en/

Contacts

Inquiries

Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774

Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005

Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116